Clinical Trials Browser

OTHER × Interventional × Urate Oxidase × Clear all

NCT04745910 2025-12-18

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Phase 4 Active not recruiting

Other hematologic neoplasm

Tumor Lysis Syndrome, Hematologic Neoplasms

NCT01564277 2018-01-09

Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies

Phase 2 Terminated

24 enrolled 13 charts

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma